Technical analysis of Protagenic Therapeutics, Inc. (PTIX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Price Performance
| 1 month | +133.33% |
| 3 months | +104.88% |
| Year-to-date | -35.38% |
| 1 year | -77.17% |
| 3 years | -96.74% |
| 5 years | -99.22% |
52-Week Range
| 52-week High | $4.55 |
| 52-week Low | $0.13 |
| Avg Volume (90d) | 15K |
Technical Indicators
| SMA 50 | $0.52 |
| SMA 200 | $0.65 |
| 30-day Volatility (annualised) | 250.1% |
| Price vs SMA 50 | +62.6% |
| Price vs SMA 200 | +29.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $2.57 | |
| 2025-11 | $2.13 | -17.1% |
| 2025-12 | $1.30 | -39.0% |
| 2026-01 | $0.48 | -63.4% |
| 2026-02 | $0.47 | -2.3% |
| 2026-03 | $0.68 | +45.8% |
| 2026-04 | $0.88 | +29.8% |
| 2026-05 | $0.54 | -38.3% |
| 2026-06 | $0.39 | -27.8% |
| 2026-07 | $0.18 | -54.1% |
| 2026-08 | $1.20 | +566.7% |
| 2026-09 | $0.84 | -30.0% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.84 |
| Market Cap | $2M |
| Exchange | OTC |
| Country | US |
Valuation Ratios
| P/E Ratio | 0.28 |
| Price / Book | 0.88 |
| EV / EBITDA | -0.35 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 0.66 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -17.34 |